文章摘要
于红梅,王洪梅,陈 颖,王晓伟,狄海伦,李 伟.r-tpa合并甘露醇治疗血管壁病变性脑梗死的临床疗效分析[J].,2017,17(4):750-752
r-tpa合并甘露醇治疗血管壁病变性脑梗死的临床疗效分析
Clinical Effect of r-tpa Combined Mannitol in Treatment of Cerebral Infarction Caused by Vascular Diseases
投稿时间:2016-09-22  修订日期:2016-10-20
DOI:10.13241/j.cnki.pmb.2017.04.039
中文关键词: r-tpa  甘露醇  血管病变性脑梗死  临床疗效
英文关键词: r-tpa  Mannitol  Cerebral infarction caused by vascular diseases  Clinical effect
基金项目:
作者单位E-mail
于红梅 河北省廊坊市第四人民医院神经内科 河北 廊坊 065700 yuhongmei_2625@163.com 
王洪梅 河北省承德医学院附属医院神经内科 河北 承德 067000  
陈 颖 河北省廊坊市第四人民医院神经内科 河北 廊坊 065700  
王晓伟 河北省廊坊市第四人民医院神经内科 河北 廊坊 065700  
狄海伦 河北省廊坊市第四人民医院神经内科 河北 廊坊 065700  
李 伟 河北省廊坊市第四人民医院神经内科 河北 廊坊 065700  
摘要点击次数: 227
全文下载次数: 117
中文摘要:
      摘要 目的:观察r-tpa合并甘露醇治疗血管壁病变性脑梗死临床疗效。方法:将临床发病6 h以内的急性脑梗死患者随机分为治疗组与对照组,每组60例,治疗组用r-tpa合并甘露醇静脉滴注,对照组用川芎嗪注射液静脉滴注,对治疗组和对照组连续使用15天观察对照组和治疗组的临床疗效及神经功能恢复情况。结果:采用r-tpa合并甘露醇静脉滴注和川芎嗪静脉注射液疗效比较,治疗组总有效率93.33 %,明显优于常规治疗组78.33 %,两组差异有统计学意义(P<0.05)。两组患者治疗后CSS评分均显著低于治疗前,且治疗组明显低于对照组 (P<0.05);两组患者治疗后ADL评分均显著高于治疗前,且治疗组明显高于对照组 (P<0.05)。结论:r-tpa合并甘露醇治疗血管壁病变性脑梗死临床疗效显著,且对6个小时内没有出血倾向的血管病变性脑梗死安全实用,患者后期恢复效果良好。
英文摘要:
      ABSTRACT Objective: To explore the clinical effect of r-tpa combined mannitol in treatment of cerebral infarction caused by vascular diseases. Methods: The patients with acute cerebral infarction (ACI) within 6 hours were randomly divided into treatment group and control group with 60 cases in each group. The patients in treatment group accepted r-tpa combined mannitol, and the patients in control group accepted ligustrazine injection. The clinical efficacy and recovery of neurological function were measured after 15 days treatment. Results: The clinical effect of treatment group was 93.33 %, which was obviously higher than 78.33 % of control group with statistically significance (P<0.05). The CSS scores of two groups after treatment were obviously lower than before, and the treatment group was much lower than control group (P<0.05). The ADL scores of two groups after treatment were obviously higher than before, and the treatment group was much higher than control group (P<0.05). Conclusion: Using r-tpa combined mannitol has good effect in treatment of cerebral infarction caused by vascular diseases, which is safe and good at symptom improvement of later stage.
查看全文   查看/发表评论  下载PDF阅读器
关闭